1,25-Dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: Relationship to adenylate cyclase activation-Reference-Cited by-同舟云学术

1,25-Dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: Relationship to adenylate cyclase activation

Published:2009-12-03 Issue:6 Volume:6 Page:631-637
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Titus Louisa,Jackson Elizabeth,Nanes Mark S.,Rubin Janet E.,Catherwood Bayard D.

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.5650060614/fullpdf

Reference31 articles.

1. Modulation of PTH-stimulated cyclic AMP in cultured rodent bone cells: The effects of 1,25-(OH)2 vitamin D3 and its interaction with glucocorticoids;Chen;Calcif Tissue Int,1984

2. 1,25-Dihydroxycholecalciferol and glucocorticosteroid regulation of adenylate cyclase in an osteoblast-like cell line;Catherwood;J Biol Chem,1985

3. 1,25 Dihydroxycholecalciferol and glucocorticoid regulation of cyclic AMP-dependent protein kinase activation in an osteoblast-like cell line;Titus;Endocrinology,1988

4. Glucocorticoid and 1,25-dihydroxyvitamin D modulate the degree of cyclic AMP-dependent protein kinase isoenzyme I and II: Activation by PTH in rat osteosarcoma cells;Titus;Endocrinology,1989

5. Binding of radioiodinated parathyroid hormone to cloned bone cells;Rizzoli;Endocrinology,1983

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in mechanobiological pharmacokinetic-pharmacodynamic models of osteoporosis treatment – Pathways to optimise and exploit existing therapies;Bone;2024-09

2. Working with mineralizing extracellular vesicles. Part I: Purification techniques;Mineralizing Vesicles;2024

3. An In Silico Model for the Prediction of Changes in Mineral Density in Cortical Bone Remodeling;Journal of Biomechanical Engineering;2019-10-01

4. Application of a mechanism-based disease systems model for osteoporosis to clinical data;Journal of Pharmacokinetics and Pharmacodynamics;2013-01-12

5. Coping with time scales in disease systems analysis: application to bone remodeling;Journal of Pharmacokinetics and Pharmacodynamics;2011-10-26